Knowledge concerning the mechanisms whereby IL-17A regulates the secretion of inflammatory mediators by RPE cells may increase our insight in the pathogenesis of posterior uveitis and delineating the transactivation mechanisms may help to identify new therapeutic targets. The gene discussed is IL17A; the disease is posterior uveitis.